Rules Based Medicine, operating under the brand Q2 Solutions, is a company based in the United States that specializes in research and development within the business services industry. Founded in 2002, the company employs between 51 and 200 individuals and reported revenue of approximately $32.3 million. The company focuses on decentralized clinical trial laboratory services, emphasizing patient-centric approaches in clinical research. Their offerings include hybrid and fully remote laboratory solutions designed to enhance patient participation in clinical trials. Q2 Solutions integrates digitized laboratory services, such as online ordering and direct-to-patient shipping of specimen collection kits, point-of-care testing, and off-site sample collection, aiming to alleviate logistical burdens for patients and caregivers. The company’s commitment to improving the patient experience is evident in its focus on providing flexible options for trial participation, thereby facilitating broader access to critical research. Through these advanced decentralized clinical trial (DCT) solutions, Q2 Solutions seeks to support sponsors and enhance the efficiency and safety of clinical research while prioritizing patient care.